" /> Apremilast - CISMeF





Preferred Label : Apremilast;

NCIt synonyms : ( )-N-(2-((1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxo- 2,3-dihydro-1H-isoindol-4-yl)acetamide;

NCIt definition : An orally bioavailable, small molecule inhibitor of phosphodiesterase 4 (PDE4), with potential anti-inflammatory activity. Upon oral administration, apremilast targets, binds to and inhibits the activity of PDE4, thereby blocking cyclic adenosine monophosphate (cAMP) degradation and increasing intracellular cAMP levels. This may decrease the production of the proinflammatory cytokines including tumor necrosis factor-alpha (TNF-alpha). PDE4 is an enzyme that plays an important role in the degradation of cAMP and in cytokine production in inflammatory cells.;

UNII : UP7QBP99PN;

InChIKey : IMOZEMNVLZVGJZ-QGZVFWFLSA-N;

CAS number : 608141-41-9; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 608141-41-9 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Drug name : Otezla;

Molecule name : CC-10004; CC 10004;

NCI Metathesaurus CUI : CL545011;

Details


Keyword's position in hierarchy(ies) : arborescence

You can consult :


Nous contacter.
22/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.